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ABSTRACT
Objectives: In the USA, there is little systematic
evidence about the real-world trajectories of patient
medical care after hospice enrolment. The objective of
this study was to analyse predictors of the length of
stay for hospice patients who were admitted to hospital
in a retrospective analysis of the mandatorily reported
hospital discharge data.
Setting: All acute-care hospitals in Florida during 1
January 2010 to 30 June 2012.
Participants: All patients with source of admission
coded as ‘hospice’ (n=2674).
Primary outcome measures: The length of stay and
discharge status: (1) died in hospital; (2) discharged
back to hospice; (3) discharged to another healthcare
facility; and (4) discharged home.
Results: Patients were elderly (median age=81) with a
high burden of disease. Almost half died (46%), while
the majority of survivors were discharged to hospice
(80% of survivors, 44% of total). A minority went to a
healthcare facility (5.6%) or to home (5.2%). Only
9.2% received any procedure. Respiratory services
were received by 29.4% and 16.8% were admitted to
the intensive care unit. The median length of stay was
1 day for those who died. In an adjusted survival
model, discharge to a healthcare facility resulted in a
74% longer hospital stay compared with discharge to
hospice (event time ratio (ETR)=1.74, 95% CI 1.54 to
1.97 p<0.0001), with 61% longer hospital stays among
patients discharged home (ETR=1.61, 95% CI 1.39 to
1.86 p<0.0001). Total financial charges for all patients
exceeded $25 million; 10% of patients who appeared
to exit hospice incurred 32% of the charges.
Conclusions: Our results raise significant questions
about the ethics and pragmatics of end-of-life medical
care, and the intentions and scope of hospices in the
USA. Future studies should incorporate prospective
linkage of subjective patient-centred data and objective
healthcare encounter data.
INTRODUCTION
Hospice care is a specialised approach to
end-of-life medical care that emphasises
quality of life, pain management and
symptom alleviation for terminally ill
patients. In the USA, hospice care is usually
provided in the patient’s home or in a non-
hospital facility, and it typically excludes
curative-intent medical or surgical interven-
tions. The goal of hospice care is not to
prolong life or postpone dying, but rather to
achieve a ‘good death.’ Generally, the pre-
ferred length of enrolment in hospice is
about 6 months before death, but some
guidelines point to a recommended stay of
1 year.1 As a stipulation for receiving hospice
beneﬁts from most US insurance payers, the
patient relinquishes access to curative inter-
ventions, although the patient can opt out of
hospice at any time to regain this access. The
idealised patient trajectory that is evoked by
hospice advocates is that after patients and
families come to terms with the terminal
nature of the illness, patients will live out the
remainder of their days peacefully at home
Strengths and limitations of this study
▪ One of the largest studies until now to explore
acute-care hospitalisations of hospice patients, a
neglected aspect of the dying patient’s
experience.
▪ Recent, unbiased and comprehensive surveil-
lance data from the fourth largest state in the
USA (Florida) were analysed.
▪ Detailed analyses of morbidities, in-hospital pro-
cedures, length of hospital stay and financial
charges were included for four distinct patient
groups: patients who died, those who returned
to hospice, those who were transferred and
those who went home without hospice care.
▪ Limitations included probable under-reporting of
hospice as source of admission; inability to dis-
tinguish which morbidity was the terminal illness
and lack of information about patient/caregiver
preferences for end-of-life care and place of
death.
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or in a hospice facility with minimal medical interven-
tion prior to death.
However, there is very little systematic evidence about
the real-world trajectories of patient medical care after
hospice enrolment in the USA. Instead, previous hospice
studies have focused on whether the use of hospice or
advanced directives decrease the cost of end-of-life care2–4
or increase the quality of life before death.5 6 These
studies of cost and quality of life have generally assumed
the idealised trajectory of hospice care, without consider-
ing the possible impact of hospitalisations. Previous
reports on the phenomenon of post-hospice hospital
admissions have been small cohorts7 or single-centre
studies8 9 and have found that hospitalisation of hospice
patients can not only be costly and largely preventable but
also that positive patient outcomes for interventions on
non-terminal conditions (like hip fractures) might explain
some hospice patient hospital admissions.
In this study, one of the largest so far of
hospice-to-hospital patients, we analysed very recent data
from a statewide hospital surveillance system for all inpa-
tients whose source of admission was coded as ‘hospice.’
We report patient demographics and clinical character-
istics; hospitalisation procedures, duration and out-
comes; and detailed ﬁnancial charges. Finally, we
modelled predictors of length of hospital stay for the
majority of these terminally ill hospice patients who sur-
vived to discharge. Given that one of the core goals of
hospice programmes in the USA is to avoid unnecessary
and futile medical care at the end of life, we presumed
that a long hospital stay would constitute a negative and
unwanted outcome for most hospice patients.
METHODS
Our study population consisted of all patients at Florida
acute care hospitals whose source of admission was
coded ‘hospice’ in the state hospital discharge surveil-
lance system. Other common sources of admission
include emergency department, hospital transfer,
patient home and skilled nursing facility. In 2010, the
reporting requirements were modiﬁed and a new code
to identify hospice patients was added. In this study, we
aggregated 2.5 years of data (1 January 2010 to 30 June
2012) for analysis.
Hospitals in Florida are mandated by state law to
submit detailed discharge records of all patients.
Consequently, these data can be considered a surveil-
lance system with 100% coverage. Data items available
include patient demographics, payer, length of stay,
admission diagnosis, principal diagnosis, up to 30 sec-
ondary diagnoses, principal and secondary procedure
codes and detailed ﬁnancial charge data.
We analysed data for four distinct groups based on dis-
charge status/destination. The groups were (1) patients
who died prior to discharge; (2) patients who were dis-
charged back to hospice (either home hospice care or a
hospice facility); (3) patients who were discharged to a
healthcare facility (including transfer to another acute-
care hospital, skilled nursing facility, intermediate-care,
long-term care or rehabilitation facility); and (4) patients
who were discharged home (either with or without home
health assistance, but without hospice). For each of our
four study groups, we calculated prevalence rates for
common admission diagnoses, any-mention diagnoses
and procedures. Speciﬁcally, ‘any-mention diagnosis’ was
based on any mention of a condition in any of 32 diagno-
sis ﬁelds (including admission diagnosis, principal diag-
nosis and secondary diagnosis ﬁelds). Multiple ICD-9-CM
codes were combined into categories in some cases.
Patients with a diagnosis of heart failure included those
with chronic, acute exacerbation or both. A diagnosis of
psychosis included those who were suffering from serious
behavioural effects of Alzheimer’s disease. While the
principal diagnosis code is intended to capture the most
serious medical condition suffered by the patient (eg,
lung cancer), the admission diagnosis code is intended
to identify why the patient was admitted as an inpatient
to the hospital (eg, acute respiratory failure).
Consequently, admission diagnosis codes may include dis-
eases, symptoms, signs or ‘V-codes’, which are ICD-9-CM
codes that describe social circumstances, medical history
or other pertinent patient information not captured by
traditional organ system-based disease codes. For
example, the code V66.7 indicates an episode of palliative
healthcare.
Payer categories included Medicare (federal govern-
ment health insurance for the elderly), Medicaid
(federal/state health insurance for low-income persons),
Tricare (federal health insurance for military personnel
and their dependants), commercial (all non-government
health insurance plans including employer-provided
plans) and other (including self-pay/underinsured,
charity, worker’s compensation and other miscellaneous
small programmes).
Procedures (up to 31 per patient) were identiﬁed by
ICD-9-CM procedure codes. Procedures could include
major therapeutic interventions (eg, surgery), minor
therapeutic interventions (eg, breathing treatment),
diagnostic procedures (eg, MRI, CT scan and colonos-
copy) and minor routine procedures (eg, insertion of
catheters).
Given that hospital ﬁnancial coverage is constrained
by some payers for hospice patients based on length of
stay, we examined predictors of duration of hospital stay
using a Weibull accelerated failure (event) time survival
model.10 The Weibull model permits calculation of
‘event time ratios (ETRs)’, which are a more appropriate
measure of effect for this study than HRs. This is
because our primary interest is not in whether or not an
event occurs (all patients eventually leave the hospital),
but in whether there are factors that accelerate or delay
time to event (ie, days until discharge). ETRs provide a
proportional measure of direct impact on time to event
(eg, an ETR of 1.25=a 25% increase in the length of hos-
pital stay). We ﬁrst ﬁt a model with a large number of
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potential predictors. For the ﬁnal model, we retained all
covariates with an initial p value ≤0.15.
In addition, some payers will cover occasional hospita-
lisations of limited duration (eg, ≤5 days) for hospice
patients, for the purposes of respite care or medical
attention to a condition which is not the terminal
illness.1 11 Therefore, we used a multivariate logistic
regression model to examine the dichotomous outcome
of long (≥6 days) vs short (≤5 days) hospital stays
among survivors.
Finally, we examined detailed ﬁnancial charge data
available for each patient as a proxy for costs. We evalu-
ated which charge centres (eg, pharmacy and intensive
care) were contributing to total costs both overall and
stratiﬁed by patient discharge status. We report the per-
centage of patients with a non-$0 charge in a given
charge centre, and the median and 99th centile dollar
values (calculated based only on the distribution of
non-$0 values).
This study was classiﬁed as non-human subjects
research by the USF Institutional Review Board because
it relied solely on de-identiﬁed secondary database
analyses.
RESULTS
Patient discharge status
There were a total of 2764 patients whose source of
admission was reported as ‘hospice’ during the period 1
January 2010 to 30 June 2012 at acute-care general hos-
pitals in Florida. The discharge status of these patients is
shown in ﬁgure 1. Almost half of these patients died
prior to discharge (46%), while the majority of survivors
were discharged back into a hospice programme (80%
of survivors, 44% of total). Patients discharged home
(5.2%) included those who were scheduled to receive
home healthcare.
Patient characteristics, diagnoses and length of stay
Characteristics of patients by discharge status are shown
in table 1. The overall median age was 81 years (range
0–106 years); however, non-trivial minorities of each
group were aged <65 years (12.8–45.7%), and 5% of the
patients discharged home were markedly younger than
the other three groups (median age=67). The majority
of patients were White non-Hispanic (70.8%), followed
by Hispanic (19.9%). The majority of patients had
Tricare health insurance (51.5%), followed by other
(25.4%), private/commercial insurance (16.8%) and
Medicare or Medicaid (6.3%).
As expected, these terminally ill patients suffered a
high burden of serious illness. The most prevalent diag-
noses (based on any mention) are listed in table 1.
Some of these conditions were chronic diseases (eg,
hypertensive disease, any heart disease, cancer and
chronic obstructive pulmonary disease (COPD)), while
others probably reﬂected acute conditions that may have
precipitated hospital admission (eg, respiratory failure,
acute renal failure, stroke, pneumonia/inﬂuenza and
sepsis).
The median length of stay for all patients was 2 days,
with a range of 0–99 days. While only 10.7% of hospice
patients had a stay of 6 or more days, a longer length of
stay was much more prevalent among patients dis-
charged to a healthcare facility (32.9%) or home
(21.7%). In contrast, patients who died were most likely
to have a length of stay of zero days (22.8%), meaning
that those patients died on the same day that they were
admitted to the hospital.
Admission diagnoses
The top admission diagnoses for patients in our study
population are depicted in ﬁgure 2. For a terminally ill
patient suffering from multiple chronic and acute condi-
tions, the choice of a single admission diagnosis may be
somewhat arbitrary. In aggregate, however, these codes
provide a window of insight into the diverse challenges
present in medical management of the dying patient.
Top admission diagnoses among patients who were dis-
charged to a healthcare facility included palliative care
(16.1%), cancer (6%), psychosis (4.7%), altered mental
status (4%) and pneumonia/inﬂuenza (3.4%). Among
patients who were discharged home, top diagnoses
included cancer (8.7%), respiratory symptoms (7.3%),
drug/alcohol dependence (6.5%) and psychosis (6.5%).
Medical and surgical procedures
Overall, the use of procedures was very limited in this
population of terminally ill hospice patients, with only
9.2% overall receiving any procedure (table 2). Among
patients who died, 95.2% received no procedure. Invasive
mechanical ventilation was provided in 1% of these
patients, and non-invasive mechanical ventilation in 0.8%.
At least one procedure was received by 6.8% of patients
who were discharged to hospice. In this group, the two
most common principal procedures were paracentesis
(1%) and transfusion of packed cells (0.9%).
Procedure use was more common among patients who
did not return to hospice (33.6% for those who were dis-
charged to a healthcare facility and 41.3% for those who
Figure 1 Discharge outcomes for patients admitted to a
hospital from hospice, Florida 2010–2012 (n=2674).
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were discharged home). Top procedures for hospice
patients discharged to a healthcare facility were percutan-
eous endoscopic gastrostomy (PEG) (3.4%), venous cath-
eterisation (2%) and transfusion of packed cells (2%). For
patients discharged home, drug detoxiﬁcation was the top
procedure (5.1%), followed by PEG (2.2%).
Predictors of the hospital length of stay
We found several signiﬁcant predictors of length of hos-
pital stay in an accelerated event time survival analysis of
all hospice patients who survived to hospital discharge
(n=1457), as shown in table 3. ETRs signiﬁcantly <1.00
indicate predictors that shortened the length of stay (ie,
accelerated time to discharge), while ETRs signiﬁcantly
>1.00 indicate factors that delayed hospital discharge.
We ﬁrst ﬁt a model with a large number of potential pre-
dictors. For the ﬁnal model, we retained all covariates
with an initial p value ≤0.15. Potential predictors which
were NOT included in the ﬁnal model were: sex, COPD,
ischaemic heart disease, HIV, hypertensive disease, any
fracture, respiratory failure, drug/alcohol dependence,
sepsis, acute renal failure, end-stage renal disease and
Table 1 Characteristics* of patients admitted from hospice by final discharge status, Florida 2010–2012
Died before
discharge
(n=1217)
Discharged to
hospice (n=1170)
Discharged to a
healthcare facility
(n=149)
Discharged
home (n=138)
Total
(n=2764)
Median age 80 81 84 67 81
Age, years (%)
≤64 16.1 15.2 12.8 45.7 17.1
65–74 18.1 14.9 16.1 18.8 16.6
75–84 29.5 30.3 26.2 21.7 29.2
85–94 31.1 33.7 38.3 9.4 31.5
95+ 5.3 6.0 6.7 4.4 5.6
Gender (%)
Male 49.1 47.5 38.9 40.6 47.4
Female 50.9 52.5 61.1 59.4 52.6
Race/ethnicity (%)
White 73.7 69.6 72.5 52.9 70.8
Hispanic 17.0 22.5 16.8 26.8 19.9
Black 6.9 6.7 9.4 15.2 7.4
Other 2.4 1.3 1.3 5.1 2.0
Payer (%)
Medicare/Medicaid 1.3 4.2 35.6 37.0 6.3
Private insurance 14.7 19.2 6.0 26.1 16.8
Tricare/Federal 57.7 49.8 40.3 23.2 51.5
Other 26.3 26.8 18.1 13.8 25.4
12 Most prevalent diagnoses†
Hypertensive disease 37.6 46.4 62.4 50.7 43.5
Non-ischaemic heart
disease
31.1 32.1 38.3 18.8 31.3
Cancer 28.1 36.6 23.5 19.6 31.1
Respiratory failure 37.9 18.8 17.5 10.1 27.0
Ischaemic heart
disease
25.1 25.0 33.6 21.0 25.4
Chronic obstructive
pulmonary disease
23.9 25.9 27.5 21.0 24.8
Heart failure 25.4 22.3 21.5 19.6 23.5
Psychosis 15.9 28.4 43.6 28.4 23.5
Acute renal failure 16.7 13.4 18.1 10.9 15.0
Stroke 15.6 11.8 13.4 8.7 13.5
Pneumonia or
influenza
14.1 14.2 12.1 2.2 13.4
Sepsis 13.6 8.8 9.4 3.6 10.8
Median length of stay
(days)
1 2 3 3 2
Per cent with stay
>5 days
9.7 7.6 32.9 21.7 10.7
*All per cents are column per cents.
†Based on a mention in any of the 32 diagnosis fields. Each patient could have multiple diagnoses.
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senility. The only patient characteristic that shortened
hospital stay was older age. For example, compared with
those ≤64 years of age, patients aged 85–94 years had
hospital stays that were 35% shorter (ETR 0.65, 95% CI
0.58 to 0.74, p<0.0001). In contrast, several factors
lengthened hospital stays, including Medicare/Medicaid
(74% longer stays than those with private insurance),
discharge home (61% longer stays than those who
returned to hospice) or to another healthcare facility
(74% longer stays than those who returned to hospice)
and Hispanic ethnicity (12% longer stays than
non-Hispanic Whites). Clinical diagnoses that increased
the length of stay included medical complications/infec-
tions (43% longer stays than those without these diagno-
ses), stroke (29% longer stays), heart failure (18%
longer stays) and psychosis (13% longer stays). A
Figure 2 (A) Top admission diagnoses for hospice patients who died prior to hospital discharge (n=1217). (B) Top admission
diagnoses for hospice patients who were discharged back to hospice (n=1170). (C) Top admission diagnoses for hospice
patients who were discharged to a healthcare facility (n=149). (D) Top admission diagnoses for hospice patients who were
discharged home without hospice care (n=138). COPD, chronic obstructive pulmonary disease; GI, gastrointestinal.
Table 2 Most prevalent principal procedures* for hospice patients admitted to a hospital, Florida 2010–2012
Died before
discharge
(n=1217)
Discharged to
hospice (n=1170)
Discharged to a
healthcare facility
(n=149)
Discharged
home (n=138)
Total
(n=2764)
Per cent with no procedure 95.2 93.2 66.4 58.7 91.8
Mechanical ventilation for
<96 h
n=12 n=8 n=1 n=1 n=22
Venous catheterisation 6 8 3 1 18
Blood transfusion 4 11 3 0 18
Non-invasive ventilation 10 5 2 0 17
Paracentesis 1 12 1 0 14
Enteral feeding 9 2 0 0 11
Percutaneous endoscopic
gastrostomy
1 1 5 3 10
Insertion of an endotracheal
tube
4 2 2 0 8
Drug detoxification 0 0 0 7 7
Haemodialysis 1 3 1 0 5
Radiation therapy 0 3 1 1 5
Interruption of vena cava 0 2 1 1 4
Mechanical ventilation ≥96 h 1 1 2 0 4
*All per cents are column per cents. Each patient had one (or no) principal procedure listed.
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diagnosis of cancer did not affect the length of hospital
stay (ETR 1.07, p=0.11).
Predictors of extended hospital stay
Some payers will cover occasional hospitalisations of
limited duration (eg, ≤5 days) for hospice patients, for
the purposes of respite care or medical attention to a
condition which is not the terminal illness.1 11
Therefore, we used a multivariate logistic regression
model to examine the dichotomous outcome of long
(≥6 days) vs short (≤5 days) hospital stays among survi-
vors (table 4). We found that patients ≤64 years of age
were almost twice as likely to experience a long hospital
stay (OR=1.89, 95% CI 1.08 to 3.33, p=0.03) compared
with those aged 75–84 years. Gender and race/ethnicity
did not predict the length of hospital stay. A total of 18
clinical conditions were included in the model; only 3
conditions were signiﬁcantly associated with a longer
length of stay: cancer (OR=1.80, 95% CI 1.15 to 2.79,
p=0.01), heart failure (OR=1.65, 95% CI 1.00 to 2.70,
p=0.047) and stroke (OR=1.81, 95% CI 1.07 to 3.07,
p=0.027). Patients with psychosis were 52% more likely
to have a long length of stay compared with patients
without psychosis, with borderline signiﬁcance
(OR=1.52, 95% CI 0.99 to 2.34, p=0.059).
Finally, consistent with the survival analysis results
shown in table 3, the strongest predictors of long versus
short stay were payer and discharge destination.
Compared with patients insured privately, extended hos-
pital stays were almost ﬁve times more likely among
those with Medicare or Medicaid (OR=4.87, 95% CI
2.50 to 9.51, p<0.0001), and almost three times more
likely among those insured by Tricare (OR=2.71, 95% CI
1.50 to 4.89, p=0.001). Patients who did not return to
hospice were several times more likely to have a long
hospital stay compared with those who did return to
hospice (discharge to the healthcare facility OR=4.67,
95% CI 2.94 to 7.41, p<0.0001; discharge home
OR=2.61, 95% CI 1.49 to 4.57, p=0.0008).
Table 3 Predictors of the length of hospital stay among
hospice patients who survived to discharge (n=1457):
multivariate accelerated event time survival analysis
results
Patient predictors
Event time ratio (95% CI)
(p value)
Discharge destination
Hospice 1.00 (referent)
Healthcare facility 1.74 (1.54 to 1.97) (<0.0001)
Home 1.61 (1.39 to 1.86) (<0.0001)
Age, years
≤64 1.00 (referent)
65–74 0.73 (0.64 to 0.84) (<0.0001)
75–84 0.69 (0.61 to 0.78) (<0.0001)
85–94 0.65 (0.58 to 0.74) (<0.0001)
95+ 0.72 (0.61 to 0.86) (0.0003)
Race/ethnicity
White 1.00 (referent)
Hispanic 1.12 (1.03 to 1.22) (0.01)
Black 1.06 (0.92 to 1.22) (0.44)
Other 1.82 (1.37 to 2.42) (<0.0001)
Payer
Private insurance 1.00 (referent)
Medicare/Medicaid 1.74 (1.50 to 2.02) (<0.0001)
Tricare/Federal 1.21 (1.09 to 1.34) (0.0002)
Other 0.93 (0.84 to 1.04) (0.21)
Clinical diagnoses (present vs absent)
Medical complications/
infections
1.43 (1.18 to 1.73) (0.0002)
Stroke 1.29 (1.15 to 1.44) (<0.0001)
Heart failure 1.18 (1.07 to 1.30) (0.001)
Psychosis 1.13 (1.04 to 1.23) (0.04)
Pneumonia/influenza 1.11 (1.00 to 1.24) (0.06)
Other heart disease* 0.92 (0.85 to 1.01) (0.08)
Cancer 1.07 (0.98 to 1.17) (0.11)
*Excludes ischaemic heart disease and heart failure. Includes
endocarditis, pericarditis, valve disease, cardiomyopathy,
pulmonary hypertension and other specified and ill-defined
diseases of the heart.
Table 4 Predictors of a long (≥6 days) vs short (≤5 days)
hospital stay among hospice patients who survived to
discharge (n=1457): multivariate logistic regression results
Patient predictors OR (95% CI) (p value)
Age, years
≤64 1.89 (1.08 to 3.33) (0.03)
65–74 1.65 (0.96 to 2.85) (0.07)
75–84 1.00 (referent)
85–94 0.91 (0.55 to 1.49) (0.70)
95+ 1.16 (0.51 to 2.62) (0.73)
Gender
Male 1.00 (referent)
Female 1.02 (0.71 to 1.46) (0.94)
Race/ethnicity
White 1.00 (referent)
Hispanic 1.13 (0.72 to 1.76) (0.60)
Black 1.22 (0.65 to 2.28) (0.53)
Other 1.08 (0.31 to 3.73) (0.91)
Payer
Medicare/Medicaid 4.87 (2.50 to 9.51) (<0.0001)
Private insurance 1.00 (referent)
Tricare/Federal 2.71 (1.50 to 4.89) (0.001)
Other 0.86 (0.42 to 1.76) (0.68)
Clinical diagnoses* (present vs absent)
Cancer 1.80 (1.15 to 2.79) (0.01)
Heart failure 1.65 (1.00 to 2.70) (0.047)
Stroke 1.81 (1.07 to 3.07) (0.027)
Psychosis 1.52 (0.99 to 2.34) (0.059)
Discharge destination
Hospice 1.00 (referent)
Healthcare facility 4.67 (2.94 to 7.41) (<0.0001)
Home 2.61 (1.49 to 4.57) (0.0008)
*The following diagnoses were also included in the model and all
were insignificant: chronic obstructive pulmonary disease,
ischaemic heart disease, pneumonia/influenza, HIV, hypertensive
disease, non-ischaemic heart disease, any fracture, complication
of medical devices, respiratory failure, drug/alcohol dependence,
sepsis, acute renal failure, end-stage renal disease and senility.
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Financial charges
The median hospital charge for patients admitted from
hospice was $3916 (table 5). Reﬂecting differences in
the length of stay, this value varied considerably by dis-
charge status, from $3424 for patients who died to
$13 293 for patients who were discharged home. The
most frequent charge centre was pharmacy, with 91.6%
of patients having a non-zero charge, followed by room
and board (84.4% of patients), medical/surgical sup-
plies (58.9%), respiratory services and tests (29.4%),
intensive care unit (ICU, 16.8%), laboratory (18.7%),
radiology/imaging (10.0%) and emergency department
(5.6%). Low usage levels for laboratory and radiology
are consistent with the intent of exclusion of
curative-intent treatment for hospice patients. Patients
who did not return to hospice were much more likely to
have laboratory charges (57.7 –71.0%) and radiology/
imaging charges (40.3– 44.2%). ICU usage and charges
were highest among patients discharged to a healthcare
facility and lowest among patients who died.
In summary, total charges for hospice patients admit-
ted to hospitals in Florida during our 30-month study
period exceeded $25 million (table 4). Hospice patients
who appeared to be exiting hospice care were 10%
(287/2674) of patients by number but incurred 32%
($8 021 013/$25 265 839) of the ﬁnancial charges due
to longer lengths of stay, a greater number of proce-
dures and a greater likelihood of ICU use.
DISCUSSION
This is one of the largest studies to date of a neglected
aspect of the experience of dying patients who chose to
enrol in hospice. We capitalised on a new data item added
in 2010 to Florida’s mandatory hospital discharge reporting
system which identiﬁed patients who were admitted to the
hospital from a hospice programme (either home or facility-
based). Our study revealed that 46% of patients admitted to
the hospital from hospice died before discharge and
incurred over $8 million in charges. Most of these patients
died on the day of admission or within 1–2 days after admis-
sion and did not receive life-saving procedures, although
18% were admitted to the ICU. This suggests that these hos-
pital admissions were medically unnecessary, which is
important given that hospitals are not the preferred place of
death for many patients. Research carried out on patients’
preferences regarding place of death has shown that in an
idealised trajectory of hospice care patients want to die at
home or in a hospice facility with minimal medical interven-
tion prior to death.12 However, for some patients and care-
givers, hospital admission in the ﬁnal hours or days of life
may be preferred. For future hospice research, an important
patient-centred ‘outcome’ measure may be whether death
occurred in the place and context desired by the patient
and family.
A second group of patients admitted to the hospital
from hospice care returned to hospice after their stay in
the hospital. Many private insurance companies as well
as TriCare and Medicare make allowances for ‘respite
care’ hospital stays of up to 5 days’ duration in order to
give patients’ caregivers a short break. Respite care is
consistent with the top two admission diagnoses for this
group (cancer and palliative care). However, other
admission diagnoses (eg, stroke, respiratory failure/
symptoms, sepsis and psychosis) suggest acute illness epi-
sodes that home or hospice facility staff were unprepared
to cope with. Although there is a substantial body of
research on caregiver stress and burnout, this is gener-
ally framed as a possible threat to the health of the care-
givers themselves rather than a possible reason for
hospitalisation from hospice.13–15 Additional research on
a possible link between the preparedness of home and
hospice facility staff and acute illness episodes resulting
in hospitalisation is warranted.
Importantly, two groups of hospice patients in our
study—those discharged to a healthcare facility and
those discharged home—were patients whose admission
to the hospital most likely denoted a rejection of
hospice care. This hypothesis is consistent with our
observations that these two groups were more likely to
have a stay longer than 5 days, had higher rates of pro-
cedure use, and incurred median ﬁnancial charges that
were much higher than those who died or returned to
hospice. Although this was a small group of patients,
further study on the phenomenon of terminally ill
patients exiting hospice treatment is needed.
Study limitations
Data about the total number of hospice patients in the
state of Florida during our study period were not readily
available. Hospice care is not subject to regular surveil-
lance, and the large number of relatively small providers
of hospice care makes ascertainment of denominator
estimates difﬁcult. On the basis of a recent report from
a professional organisation,16 we roughly estimate that
there 120 000 hospice patients annually during our
study period in Florida. This would translate to about
1% of hospice patients being admitted to hospital.
However, while hospital discharge data systems have
been shown to be reasonably valid sources of patient
information17–21 and are widely used,22–25 we believe this
new variable to be signiﬁcantly under-reported, and that
the true number of hospice patients admitted was
higher. In particular, patients who are admitted via the
emergency department (as opposed to a direct admis-
sion by the physician) may be less likely to have their
hospice status recorded in the medical record.
A second limitation of our study is that these termin-
ally ill patients suffered from multiple chronic and acute
diseases and we did not have access to data which identi-
ﬁed the initial reason for referral to hospice. An import-
ant empirical question is whether the healthcare
trajectories of patients dying from cancer, for example,
differ in signiﬁcant ways from those dying from congest-
ive heart failure or COPD.
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A ﬁnal limitation of this study is the lack of informa-
tion available about patient and family/caregiver
decision-making and preferences in relation to hospice
care, hospital admission, ICU admission and use of
interventions such as mechanical ventilation and blood
transfusions. For the patients who died, it is unknown
whether dying in the hospital (often shortly after admis-
sion) was in accord with patients’ and caregivers’ wishes,
or represented last-minute failures of hospice care to
shield patients from unwarranted medical intervention.
Conclusions and future directions
Our results and those of previous studies2–9 raise difﬁcult
and signiﬁcant questions about the ethics and pragmatics
of end-of-life medical care and the intentions and scope of
hospice care. Commonly used templates for patient
advance directive documents, for example, 5 Wishes,26
include lists of ‘life-support treatment’ that patients may
want to avoid, such as cardiopulmonary resuscitation,
mechanical ventilation, tube feeding, major surgery, blood
transfusions, dialysis and antibiotics. In our study, the use
of procedures was very low, except among patients who
survived and did not return to hospice. In a report on
hospice patients with hip fracture,7 83% received hip
surgery and consequently had improved survival com-
pared with those who did not undergo surgery. Patients
dying of a terminal disease (eg, cancer) may experience
painful and/or life-threatening acute illness events that
are completely unrelated in pathology (eg, stroke or hip
fracture), and which were not directly addressed in
advance directives or hospice care plans. Patients, care-
givers and healthcare providers may all ﬁnd themselves
uncertain about the most ethical and compassionate
course of action in these situations.
Table 5 Detailed financial charges for patients admitted from hospice by final discharge status, Florida 2010–2012
Charge centres (listed in
order of decreasing
frequency)
Died before
discharge
(n=1217)
Discharged to
hospice (n=1170)
Discharged to a
healthcare facility
(n=149)
Discharged
home (n=138)
Total
(n=2764)
Total
Per cent with any charge 100 100 100 100 100
Median ($) 3424 3634 11 133 13 293 3916
99th centile ($) 46 755 59 606 310 900 252 858 100 431
Total for all patients ($) 8 041 068 9 203 758 4 074 703 3 946 310 25 265 839
Pharmacy
Per cent with any charge 86.9 95.0 98.0 97.8 91.6
Median ($) 434 562 1949 1427 586
99th centile ($) 25 727 17 099 43 220 34 186 24 322
Room and board
Per cent with any charge 83.0 86.3 81.9 82.6 84.4
Median ($) 1802 1730 4290 3912 2106
99th centile ($) 20 400 16 843 31 898 49 462 22 185
Medical/surgical supplies
Per cent with any charge 48.7 67.4 68.5 66.7 58.9
Median ($) 484 484 1,167 548 525
99th centile ($) 9942 8476 17 892 193 544 15 048
Respiratory services/tests
Per cent with any charge 23.0 33.9 35.6 40.6 29.4
Median ($) 522 585 851 548 571
99th centile ($) 16 240 7174 78 726 16 050 16 240
Intensive care unit
Per cent with any charge 17.9 14.4 24.8 19.6 16.8
Median ($) 3071 2831 5542 1915 2990
99th centile ($) 16 276 38 300 62 350 29 505 32 505
Laboratory
Per cent with any charge 6.9 19.9 57.7 71.0 18.7
Median ($) 506 1041 3337 1915 1368
99th centile ($) 62 577 37 357 41 047 35 428 37 357
Radiology/imaging
Per cent with any charge 2.7 9.7 40.3 44.2 10.0
Median ($) 1728 1475 3135 2310 2018
99th centile ($) 61 895 22 079 61 070 43 598 48 922
Emergency department
Per cent with any charge 1.9 4.6 24.2 26.1 5.6
Median ($) 1999 1886 1647 1786 1851
99th centile ($) 5089 6134 7189 5130 6134
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We would advocate inclusion of a simple hospice indica-
tor in additional clinical registries and hospital reporting
systems, as this would be a low-cost means of creating add-
itional data resources for exploring hospice patient health-
care trajectories. Future studies should investigate variations
in hospice patient healthcare trajectories by cause of ter-
minal illness, as well as incorporate patient and caregiver
needs and preferences. An ideal study design would pro-
spectively link subjective patient-centred data (eg, advance
directive content, do not resuscitate, patient-reported values
and preferences) and objective healthcare encounter data
(eg, emergency room visits, inpatient stays and outpatient
care).
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